News | June 02, 2022
Vial to launch oncology CRO, Arati Rao named as First Advisor
The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.
The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.
Olumiant is the first and only JAK inhibitor USFDA-approved for the treatment of Covid-19
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
According to the National Institutes of Health, more than six million Americans, most age 65 or older, may have dementia caused by Alzheimer's disease, a brain disorder known to slowly destroy memory and thinking skills
Three RFPs now open for qualified researchers through NORD's Jayne Holtzer rare disease research grants program
Star Array's focus has been on the development of an automated (cassette-based) nucleic acid purification system coupled with its superfast nucleic acid amplification technology
If authorized by the USFDA, the Proof Lab Test System may be used to deliver accurate, actionable, lab-quality results for Covid-19 in as little as 18 minutes
All of Us Research Program releases genomic data to researchers, combined with participant-generated data collected on Vibrent Health’s research platform
The open-label, multicenter, randomized Phase 1 trial is designed to evaluate the safety and immunogenicity of experimental HIV trimer mRNA vaccines
Moderna's Omicron-specific bivalent booster candidate combines its Omicron-specific booster candidate with its Covid-19 vaccine
Subscribe To Our Newsletter & Stay Updated
